Reducing the frequency of outpatient review in people with cystic fibrosis on high-efficacy modulator therapy – a non-inferiority, randomised controlled trial (REFORM) (ACTRN12624000696594)
REFORM
This trial is No longer recruiting
Registration number ACTRN12624000696594
Program & service
This trial is being run with the Heart & Lung service, and as part of the Respiratory program.
Trial phase
Phase 3
Trial participation type
This trial is for clinical research of something other than a drug or device.
Principal investigator
Professor Peter Wark
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR